Relacore Tablets
Natural health product licensed in Canada
- Other names
- Relacore Advanced
- Licence holder
- The Carter-Reed Company, LLC
- NPN or DIN-HM
- 80041708
- Status
- Active licence
- Licence date
- 16 April 2013
- Revision date
- 7 June 2019
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax ginseng Source : Racine Extraction ratio : 5:1 Dry plant equivalent : 1.665 mg Potency : 26.64 mcg Total ginsenosides | 333 mcg | Not calculated |
| Vitamine B12 Source : Vitamine B12 | 3.33 mcg | 9.99 µg |
| Folate Source : Folate | 133.33 mcg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 33.34 mg | 100,020 µg |
| Passiflora incarnata Source : Plante | 33.34 mg | Not calculated |
| Magnolia officinalis Source : Écorce (tige) | 33.34 mg | Not calculated |
Non-medicinal ingredients
Laque d'aluminium jaune FD&C No. 5, Laque d'aluminiium FD&C rouge n° 40, Poly(alcool vinylique), Silice, Poly(sorbate) 80, Macrogol 3350, Pigments nacrés à base de mica, Talc, Acide stéarique, Gel de silice, Laque d'aluminium bleu FD&C n° 1, Cellulose microcristalline, Croscarmellose de sodium, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce symptoms of mild stress. Helps to reduce symptoms of mild anxiety. Helps the body to metabolize carbohydrates, proteins, and fats.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) to Passionflower has been know to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80041708
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.